HA Viscosupplementation - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510245082

Publication Date:

October 29, 2024

Pages:

131

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
The global market for HA Viscosupplementation was estimated to be worth US$ 1822 million in 2023 and is forecast to a readjusted size of US$ 2329.4 million by 2030 with a CAGR of 3.6% during the forecast period 2024-2030
Viscosupplementation involves the injection of hyaluronic acid-based solutions into the joints to relieve pain and improve mobility in patients with osteoarthritis. Factors driving market growth include the increasing prevalence of osteoarthritis, growing aging population, and the effectiveness of viscosupplementation in managing symptoms. The market is highly competitive, with several manufacturers offering viscosupplementation devices. However, challenges such as limited insurance coverage, high treatment costs, and the availability of alternative therapies may hinder market expansion. Nonetheless, the viscosupplementation devices market holds promising opportunities, driven by the rising demand for non-surgical treatment options for osteoarthritis and ongoing research and development efforts to enhance the efficacy of viscosupplementation products.
Report Scope
This report aims to provide a comprehensive presentation of the global market for HA Viscosupplementation, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of HA Viscosupplementation by region & country, by Type, and by Application.
The HA Viscosupplementation market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HA Viscosupplementation.
麻豆原创 Segmentation
By Company
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
Segment by Type:
Single Injection
Three Injection
Five Injection
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of HA Viscosupplementation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of HA Viscosupplementation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of HA Viscosupplementation in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 HA Viscosupplementation Product Introduction
1.2 Global HA Viscosupplementation 麻豆原创 Size Forecast
1.2.1 Global HA Viscosupplementation Sales Value (2019-2030)
1.2.2 Global HA Viscosupplementation Sales Volume (2019-2030)
1.2.3 Global HA Viscosupplementation Sales Price (2019-2030)
1.3 HA Viscosupplementation 麻豆原创 Trends & Drivers
1.3.1 HA Viscosupplementation Industry Trends
1.3.2 HA Viscosupplementation 麻豆原创 Drivers & Opportunity
1.3.3 HA Viscosupplementation 麻豆原创 Challenges
1.3.4 HA Viscosupplementation 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global HA Viscosupplementation Players Revenue Ranking (2023)
2.2 Global HA Viscosupplementation Revenue by Company (2019-2024)
2.3 Global HA Viscosupplementation Players Sales Volume Ranking (2023)
2.4 Global HA Viscosupplementation Sales Volume by Company Players (2019-2024)
2.5 Global HA Viscosupplementation Average Price by Company (2019-2024)
2.6 Key Manufacturers HA Viscosupplementation Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers HA Viscosupplementation Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of HA Viscosupplementation
2.9 HA Viscosupplementation 麻豆原创 Competitive Analysis
2.9.1 HA Viscosupplementation 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by HA Viscosupplementation Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HA Viscosupplementation as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Single Injection
3.1.2 Three Injection
3.1.3 Five Injection
3.2 Global HA Viscosupplementation Sales Value by Type
3.2.1 Global HA Viscosupplementation Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global HA Viscosupplementation Sales Value, by Type (2019-2030)
3.2.3 Global HA Viscosupplementation Sales Value, by Type (%) (2019-2030)
3.3 Global HA Viscosupplementation Sales Volume by Type
3.3.1 Global HA Viscosupplementation Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global HA Viscosupplementation Sales Volume, by Type (2019-2030)
3.3.3 Global HA Viscosupplementation Sales Volume, by Type (%) (2019-2030)
3.4 Global HA Viscosupplementation Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global HA Viscosupplementation Sales Value by Application
4.2.1 Global HA Viscosupplementation Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global HA Viscosupplementation Sales Value, by Application (2019-2030)
4.2.3 Global HA Viscosupplementation Sales Value, by Application (%) (2019-2030)
4.3 Global HA Viscosupplementation Sales Volume by Application
4.3.1 Global HA Viscosupplementation Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global HA Viscosupplementation Sales Volume, by Application (2019-2030)
4.3.3 Global HA Viscosupplementation Sales Volume, by Application (%) (2019-2030)
4.4 Global HA Viscosupplementation Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global HA Viscosupplementation Sales Value by Region
5.1.1 Global HA Viscosupplementation Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global HA Viscosupplementation Sales Value by Region (2019-2024)
5.1.3 Global HA Viscosupplementation Sales Value by Region (2025-2030)
5.1.4 Global HA Viscosupplementation Sales Value by Region (%), (2019-2030)
5.2 Global HA Viscosupplementation Sales Volume by Region
5.2.1 Global HA Viscosupplementation Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global HA Viscosupplementation Sales Volume by Region (2019-2024)
5.2.3 Global HA Viscosupplementation Sales Volume by Region (2025-2030)
5.2.4 Global HA Viscosupplementation Sales Volume by Region (%), (2019-2030)
5.3 Global HA Viscosupplementation Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America HA Viscosupplementation Sales Value, 2019-2030
5.4.2 North America HA Viscosupplementation Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe HA Viscosupplementation Sales Value, 2019-2030
5.5.2 Europe HA Viscosupplementation Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific HA Viscosupplementation Sales Value, 2019-2030
5.6.2 Asia Pacific HA Viscosupplementation Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America HA Viscosupplementation Sales Value, 2019-2030
5.7.2 South America HA Viscosupplementation Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa HA Viscosupplementation Sales Value, 2019-2030
5.8.2 Middle East & Africa HA Viscosupplementation Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions HA Viscosupplementation Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions HA Viscosupplementation Sales Value
6.2.1 Key Countries/Regions HA Viscosupplementation Sales Value, 2019-2030
6.2.2 Key Countries/Regions HA Viscosupplementation Sales Volume, 2019-2030
6.3 United States
6.3.1 United States HA Viscosupplementation Sales Value, 2019-2030
6.3.2 United States HA Viscosupplementation Sales Value by Type (%), 2023 VS 2030
6.3.3 United States HA Viscosupplementation Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe HA Viscosupplementation Sales Value, 2019-2030
6.4.2 Europe HA Viscosupplementation Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe HA Viscosupplementation Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China HA Viscosupplementation Sales Value, 2019-2030
6.5.2 China HA Viscosupplementation Sales Value by Type (%), 2023 VS 2030
6.5.3 China HA Viscosupplementation Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan HA Viscosupplementation Sales Value, 2019-2030
6.6.2 Japan HA Viscosupplementation Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan HA Viscosupplementation Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea HA Viscosupplementation Sales Value, 2019-2030
6.7.2 South Korea HA Viscosupplementation Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea HA Viscosupplementation Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia HA Viscosupplementation Sales Value, 2019-2030
6.8.2 Southeast Asia HA Viscosupplementation Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia HA Viscosupplementation Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India HA Viscosupplementation Sales Value, 2019-2030
6.9.2 India HA Viscosupplementation Sales Value by Type (%), 2023 VS 2030
6.9.3 India HA Viscosupplementation Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Company Information
7.1.2 Sanofi Introduction and Business Overview
7.1.3 Sanofi HA Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Sanofi HA Viscosupplementation Product Offerings
7.1.5 Sanofi Recent Development
7.2 Anika Therapeutics
7.2.1 Anika Therapeutics Company Information
7.2.2 Anika Therapeutics Introduction and Business Overview
7.2.3 Anika Therapeutics HA Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Anika Therapeutics HA Viscosupplementation Product Offerings
7.2.5 Anika Therapeutics Recent Development
7.3 Seikagaku
7.3.1 Seikagaku Company Information
7.3.2 Seikagaku Introduction and Business Overview
7.3.3 Seikagaku HA Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Seikagaku HA Viscosupplementation Product Offerings
7.3.5 Seikagaku Recent Development
7.4 Zimmer Biomet
7.4.1 Zimmer Biomet Company Information
7.4.2 Zimmer Biomet Introduction and Business Overview
7.4.3 Zimmer Biomet HA Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Zimmer Biomet HA Viscosupplementation Product Offerings
7.4.5 Zimmer Biomet Recent Development
7.5 Bioventus
7.5.1 Bioventus Company Information
7.5.2 Bioventus Introduction and Business Overview
7.5.3 Bioventus HA Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Bioventus HA Viscosupplementation Product Offerings
7.5.5 Bioventus Recent Development
7.6 Ferring
7.6.1 Ferring Company Information
7.6.2 Ferring Introduction and Business Overview
7.6.3 Ferring HA Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Ferring HA Viscosupplementation Product Offerings
7.6.5 Ferring Recent Development
7.7 LG Chem
7.7.1 LG Chem Company Information
7.7.2 LG Chem Introduction and Business Overview
7.7.3 LG Chem HA Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
7.7.4 LG Chem HA Viscosupplementation Product Offerings
7.7.5 LG Chem Recent Development
7.8 Freda
7.8.1 Freda Company Information
7.8.2 Freda Introduction and Business Overview
7.8.3 Freda HA Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Freda HA Viscosupplementation Product Offerings
7.8.5 Freda Recent Development
7.9 Haohai Biological
7.9.1 Haohai Biological Company Information
7.9.2 Haohai Biological Introduction and Business Overview
7.9.3 Haohai Biological HA Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Haohai Biological HA Viscosupplementation Product Offerings
7.9.5 Haohai Biological Recent Development
7.10 Shanghai Jingfeng
7.10.1 Shanghai Jingfeng Company Information
7.10.2 Shanghai Jingfeng Introduction and Business Overview
7.10.3 Shanghai Jingfeng HA Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Shanghai Jingfeng HA Viscosupplementation Product Offerings
7.10.5 Shanghai Jingfeng Recent Development
8 Industry Chain Analysis
8.1 HA Viscosupplementation Industrial Chain
8.2 HA Viscosupplementation Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 HA Viscosupplementation Sales Model
8.5.2 Sales Channel
8.5.3 HA Viscosupplementation Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.